M3 Inc traded at 1,591.50 this Wednesday March 25th, decreasing 2.50 or 0.16 percent since the previous trading session. Looking back, over the last four weeks, M3 lost 2.27 percent. Over the last 12 months, its price fell by 6.74 percent. Looking ahead, we forecast M3 Inc to be priced at 1,538.70 by the end of this quarter and at 1,348.19 in one year, according to Trading Economics global macro models projections and analysts expectations.
M3 Inc is a Japan-based company mainly engaged in the provision of services centering on the platform of healthcare. The Company has five business segments. Medical Platforms segment conducts marketing-related businesses in Japan utilizing the Internet and real operations centered on medical employee specialized site m3.com. Evidence Solution segment is involved in the contract research organization (CRO) business that supports clinical development work and research, and site management organization (SMO) business that manages the clinical trial operations. Career Solutions segment is engaged in human resource services for healthcare professionals. Site Solution segment provides operational support for medical institutions and home-visit nursing services. Overseas segment provides services of medical related marketing support, research and careers, utilizing the medical employee specialized sites in the United States, the United Kingdom, China, Korea, India, France, Germany and Spain.